Medifast, Inc.
MED
NYSE·Consumer Cyclical·Personal Products & Services·Mkt cap $140.4M
$12.63
▲ +0.72%
P/E
-5.42
Mkt Cap
$140.4M
52-Wk Range
$9.22–$14.67
52-Week Range
$9.22 - $14.67
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 8.6% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Proprietary OPTAVIA program combining products with personalized coaching for customer retention
- Established brand recognition and 40+ year track record in weight management industry
- Vertically integrated manufacturing and direct distribution model reducing intermediaries
- Coach-based network creating community engagement and recurring revenue streams
Bear Case
1 risk
- Low volatility (beta 0.7).
Growth
Mild headwinds expected
Rising obesity rates and consumer demand for structured weight management solutions
Value
Deep value opportunity - significant discount to Professional Services peers
Momentum
Stable
+4.6% over 3m
Quality
Excellent
Mixed fundamentals
Dividend
None
No dividend
Smart-money signal
Who's buying MED right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 2, 2026
AUG 3, 2026
Reported EPS of -$0.28 vs -$0.65 consensus (+56.9% surprise). Revenue of $76.4M vs $72.7M expected (+5.1%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+56.9%
Revenue trend · last 8Q
—
-38%
-34%
-37%
-36%
-37%
-34%
-28%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$140.2M
$119.0M
$115.7M
$105.6M
$89.4M
$75.1M
$76.0M
$76.4M
Margins · last 8Q
Gross
69.9%
Operating
-8.5%
Profit
-4.1%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How MED stacks vs Personal Products & Services
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related